Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
528 |
|
Actual shortage: | 79 (15%) | |
Anticipated shortage: | 10 (2%) | |
Avoided shortage: | 14 (3%) | |
Resolved: | 425 (80%) | |
Discontinuation Reports |
69 |
|
To be discontinued: | 8 (12%) | |
Discontinued: | 51 (74%) | |
Reversed: | 10 (14%) | |
Late reports |
52 (9%) |
|
Overdue reports |
29 (30%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SILDENAFIL | 100MG | TABLET | Resolved | 2024-03-25 | 2024-04-23 | 223262 |
SIMVASTATIN | 20MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54783 |
SIMVASTATIN | 5MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54790 |
SIMVASTATIN | 40MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54794 |
SIMVASTATIN | 80MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54798 |
SIMVASTATIN | 10MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54802 |
SNS-ASA EC | 80MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-16 | 2023-09-10 | 187303 |
SOLIFENACIN | 5MG | TABLET | Resolved | 2019-06-10 | 2019-10-10 | 86061 |
SOLIFENACIN | 10MG | TABLET | Resolved | 2019-06-10 | 2019-10-10 | 86064 |
SOLIFENACIN | 5MG | TABLET | Avoided shortage | 2022-04-05 | 2022-10-20 | 157901 |
SOLIFENACIN | 10MG | TABLET | Resolved | 2023-07-31 | 2024-02-12 | 200459 |
SOLIFENACIN | 5MG | TABLET | Resolved | 2023-09-26 | 2023-12-01 | 205212 |
SOLIFENACIN | 5MG | TABLET | Resolved | 2024-01-30 | 2024-06-27 | 217809 |
SOLIFENACIN | 10MG | TABLET | Resolved | 2024-02-26 | 2024-03-08 | 220673 |
SOLIFENACIN | 10MG | TABLET | Resolved | 2024-05-28 | 2024-09-05 | 228966 |
SOLIFENACIN | 5MG | TABLET | Resolved | 2024-08-01 | 2024-10-01 | 234204 |
SOLIFENACIN | 10MG | TABLET | Actual shortage | 2024-09-09 | 2024-09-10 | 236973 |
TADALAFIL | 20MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200474 |
TADALAFIL | 5MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200477 |
TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-22 | 2024-07-05 | 211102 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |